LGBT testimony and the limits of trust

Bibliographic Data

ID21513899
AuthorsMaura Priest (0000-0001-6962-993X, Arizona State University, corresponding author)
Year2022
Volume48
Issue3
Pages200-201
Publication date2022-03-01
Open AccessNo
TypeARTICLE
VenueJournal of Medical Ethics (JOURNAL)
Journal identifiersISSN: 0306-6800 • E-ISSN: 1473-4257
PublisherBMJ (PUBLISHER • GB)
DOI10.1136/medethics-2020-106841
PMID34103366
OpenAlexW3129657037
LanguageEN
References cited13

In, ‘Forever young: the ethics of ongoing puberty suppression (OPS) for non-binary adults,’ Notini et al discuss the risks, harms and benefits of treating non-binary patients via identity-affirming OPS. Notini et al ’s article makes a strong case for OPS’s permissibility, and their conclusion will not be disputed here. Instead, I directly focus on issues that their article addressed only indirectly. This article will use a hypothetical case study to show that while Notini et al ’s ethical conclusion might be spot on, that perhaps the method they took to get there was superfluous. If the medical community is to take LGBT testimony seriously (as they should) then it is no longer the job of physicians to do their own weighing of the costs and benefits of transition-related care. Assuming the patient is informed and competent, then only the patient can make this assessment, because only the patient has access to the true weight of transition-related benefits. Moreover, taking LGBT patient testimony seriously also means that parents should lose veto power over most transition-related paediatric care

Political science · Veto · Ethics and Legal Issues in Pediatric Healthcare · Law · LGBTQ Health, Identity, and Policy · Medicine · Psychology · Reproductive Health and Technologies · Social Psychology

Tools

Open DOIOpen Access